Boxer Capital, Llc Tango Therapeutics, Inc. (TNGX) insider trading activity

Boxer Capital, LLC is of Tango Therapeutics, Inc.. Currently has a direct ownership of 8.2 Million shares of TNGX, which is worth approximately $89.3 Million. The most recent transaction as insider was on Oct 16, 2023, when has been sold 500,000 shares (Common Stock) at a price of $6.84 per share, resulting in proceeds of $3,420,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.2M

0% 3M change

15.09% 12M change

Total Value Held $89.3 Million

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2023	BUY Open market or private purchase	$3,420,000 $6.84 p/Share	500,000 Added 5.75%	8,198,642 Common Stock
Oct 13 2023	BUY Open market or private purchase	$5,302,500 $7.07 p/Share	750,000 Added 8.88%	7,698,642 Common Stock
Oct 09 2023	SELL Open market or private sale	$1,744,750 $9.97 p/Share	175,000 Reduced 2.46%	6,948,642 Common Stock
Oct 13 2022	BUY Open market or private purchase	$325,500 $4.65 p/Share	70,000 Added 0.97%	7,123,642 Common Stock
Oct 12 2022	BUY Open market or private purchase	$221,500 $4.43 p/Share	50,000 Added 15.7%	268,524 Common Stock
Oct 11 2022	BUY Open market or private purchase	$497,250 $4.25 p/Share	117,000 Added 34.87%	218,524 Common Stock
Oct 06 2022	BUY Open market or private purchase	$285,800 $4.06 p/Share	70,394 Added 0.99%	7,053,642 Common Stock
Oct 05 2022	BUY Open market or private purchase	$334,540 $3.89 p/Share	86,000 Added 1.22%	6,983,248 Common Stock
Oct 04 2022	BUY Open market or private purchase	$93,974 $3.67 p/Share	25,606 Added 0.37%	6,897,248 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

TYRA

Tyra Biosciences, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

BCL